This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Caliber Imaging & Diagnostics Releases New Products For Noninvasive, Rapid Imaging Of Living Cells

ROCHESTER, N.Y., Aug. 22, 2012 /PRNewswire/ -- Caliber Imaging & Diagnostics, formerly Lucid, Inc. (OTC Bulletin Board: LCDX), the leader in Rapid Cell Imaging and Diagnostics technology, today announced the release of two next-generation products in its FDA-cleared VivaScope ® family. The new VivaScope 1500 and VivaScope 3000 produce high-quality images of living cells at the point of care. VivaScope imagers enable physicians to perform painless "optical" biopsies to diagnose disease, by providing dynamic native views of the area of interest. In addition, VivaScope products can be used by research and development teams for claims validation as well as research into skin disease.

(Logo:  http://photos.prnewswire.com/prnh/20120822/NY61135LOGO )

Both the VivaScope 1500 and 3000 have the advantage of Caliber ID's Rapid Cell Imaging and Diagnostics technology that shows cellular detail with a resolution comparable to standard histology. Changes in the new VivaScope products include the availability of a touch-screen monitor and a multi-touch software interface that enables physicians to navigate images quickly and with the same ease as popular touch screen devices. Additionally, the Company has introduced redesigned optics and electronics for enhanced image quality and improved speed of data acquisition.

"Our Rapid Cell Imaging and Diagnosis [Rapid Cell ID] technology enables physicians to perform fast, accurate and painless 'optical biopsies' of skin," notes William J. Fox, Chief Technology Officer and Vice President of Engineering. "We have moved imaging and diagnosis out of the lab and to the point and time of care. The data shows that, in many cases, the use of our technology can eliminate the need for an invasive procedure on healthy skin, reducing costs and associated risks. The patients that we speak with love our Rapid Cell ID technology, because it's noninvasive, fast and painless with no scarring and no recuperation time!"

The VivaScope 3000 is a handheld device and offers both a small probe interface and faster imaging. The VivaScope 3000 is intended for imaging and diagnosis at the point of care and it is especially useful for hard to reach areas such as around the eyes, nose, and ears. Weighing less than 32 ounces, the VivaScope 3000 allows a physician to rapidly assess skin lesions and determine a therapeutic course of action. Current users of the VivaScope 1500 can add the capabilities of the VivaScope 3000 as an accessory to an existing device installation.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.55 -9.23 -0.44%
NASDAQ 4,966.4950 -13.4060 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs